A randomized sequential trial of creatine in amyotrophic lateral sclerosis
โ Scribed by Geert Jan Groeneveld; Jan H. Veldink; Ingeborg van der Tweel; Sandra Kalmijn; Cornelis Beijer; Marianne de Visser; John H. J. Wokke; Hessel Franssen; Leonard H. van den Berg
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 110 KB
- Volume
- 53
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract Serum creatine kinase (CK) levels were recorded in 100 patients with amyotrophic lateral sclerosis (ALS). CK concentrations were elevated in 43% of the patients, with a mean level of 240 U/liter and a range of 59โ1,327 U/liter (male normal <95 U/liter, female normal <59 U/liter). All pa
There is no satisfactory treatment for amyotrophic lateral sclerosis (ALS) [ 11. Ciliary neurotrophic factor (CNTF) is an endogenous protein that is released upon injury to the nervous system and limits the extent of injury-induced tieuronal damage in some nerve cells [2, 31. CNTF can be produced in
Fatigue in patients with mitochondrial cytopathies is associated with decreased basal and postactivity muscle phosphocreatine (PCr). Creatine monohydrate supplementation has been shown to increase muscle PCr and high-intensity power output in healthy subjects. We studied the effects of creatine mono